EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc.（EYPT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
eypt · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$39.00
Consensus
$37.50
+224.7% upside
Low
$36.00
Median: $37.5 · Last Close: $11.55
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$37.50
224.7% upside
High Target
$39
237.7%
Low Target
$36
211.8%
Current Price
$11.55
as of today
Based on analyst price targets, the EYPT stock price prediction for the next 12 months ranges from $36 to $39. The consensus EYPT price forecast of $37.50 implies 224.7% upside from the current price of $11.55.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $11.12 | ↓ 3.74% |
1-day model range: $11.06–$11.18. Peak: $11.18 (-3.74%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -33.4% |
| 2028 | $6 | -45.6% |
| 2029 | $6 | -51.1% |
| 2030 | $5 | -53.8% |
| 2031 | — | -55.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EYPT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-09 | Citigroup | Maintains | Buy→Buy |
| 2026-03-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-08-07 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-16 | Mizuho | Maintains | Outperform→Outperform |
| 2025-05-08 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on EyePoint Pharmaceuticals, Inc. (EYPT) stock. Of the recent 68 rating actions, 2 were upgrades and 2 were downgrades. 18 analysts currently cover EYPT.
分析师推荐趋势
EYPT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↓ 99.4% YoY
Revenue Next Year
$48M
↑ 2653.6% YoY
EPS This Year
$-3.54
EPS Next Year
$-2.85
↓ 19.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast EYPT EPS of $-3.54 for the current fiscal year, based on estimates from 8 analysts. The EYPT revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
EYPT 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EYPT 的共识目标价为 $37.50（+224.7% 上行空间），分析师共识为 Buy。
EYPT 的短期预测（明日）为 $11.12（-3.74%）。 EYPT 对 2027 年的股价预测均值为 $8。 EYPT 对 2030 年的预测区间为 $5–$6。
EyePoint Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 EYPT。EYPT 在 2027 年的整体展望偏积极，在覆盖分析师中约 89% 对应 Buy 共识。
常见问题
EYPT 预测 · 8 个问题根据 18 位华尔街分析师，EYPT 的 12 个月平均目标价为 $37.50，最高 $39.00、最低 $36.00。若有图表，中位目标价可在上方查看。相对当前价 $11.55，隐含约 +224.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.